gabapentin has been researched along with pemetrexed in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Katsenos, S; Panagou, C; Psara, A | 1 |
1 review(s) available for gabapentin and pemetrexed
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for gabapentin and pemetrexed
| Article | Year |
|---|---|
Pemetrexed-induced cellulitis: a rare toxicity in non-small cell lung cancer treatment.
Topics: Adrenal Cortex Hormones; Aged; Amines; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cellulitis; Cyclohexanecarboxylic Acids; Drug Monitoring; Drug Resistance, Neoplasm; Excitatory Amino Acid Antagonists; Female; Folic Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Glutamates; Guanine; Humans; Lower Extremity; Lung Neoplasms; Neurotoxicity Syndromes; Pemetrexed; Peripheral Nervous System Diseases; Treatment Outcome | 2013 |